InvestorsHub Logo
Followers 114
Posts 17287
Boards Moderated 1
Alias Born 09/12/2005

Re: AD2 post# 52470

Monday, 03/18/2013 2:23:45 PM

Monday, March 18, 2013 2:23:45 PM

Post# of 158400
THE NEXT APPROVAL IS FOR CLINICAL TRIAL TO START.

As part of the clinical trial approval process, the FDA will issue comments on the proposed trial which must be addressed to the FDA's satisfaction before patient dosing is initiated. The clinical trial will treat ten patients with aplastic anemia that have not responded to conventional therapy and lack a bone marrow donor.

http://ih.advfn.com/p.php?pid=nmona&article=56788567&symbol=BMSN

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.